<DOC>
	<DOCNO>NCT02656342</DOCNO>
	<brief_summary>In randomize control trial ( RCT ) investigator experimentally test patient Obsessive-Compulsive Disorder ( OCD ) receive treatment exposure response prevention ( ERP ) , either relapse respond , profit combination concentrate exposure base treatment ( cET ) NMDA-agonist ( N-methyl-d-aspartate ) d-cycloserine ( DCS ) , target fear relevant area amygdala pre-frontal cortex . The project expect demonstrate significant improvement group , anticipate high proportion patient receive DCS show well long-term gain treatment , compare placebo group follow-up ( 3 mon , 12 mon , 5 year treatment ) . In addition , project highlight change depression , sleep , global functioning , quality life , work social status . Changes medication use health care include related main objective study .</brief_summary>
	<brief_title>Translational Approach Understanding Treatment Obsessive-Compulsive Disorder ( OCD ) . Can D-Cycloserine Enhance Stabilize Treatment-response Relapsed Non-responding OCD-patients ?</brief_title>
	<detailed_description>A total 160 relapse non-responding OCD-patients , treat exposure response prevention ( ERP ) specialist Health care Norway , plan participate study : `` Translation approach understand treatment Obsessive-Compulsive Disorder ( OCD ) . Can D-cycloserine ( DCS ) enhance stabilize treatment-response relapse non-responding OCD-patients ? A randomized , double-blind , placebo-controlled national study . '' Estimated start inclusion November 2015 inclusion period last maximum 2 year . All participant refer specialist health care pre-screen local OCD-team . Before inclusion , patient fill number questionnaire on-line patient meet inclusion criterion invite participate . Before patient sign inform consent form patient receive write oral information study well watch video describe trial participation imply . Before 4-day concentrated exposure base treatment ( cET ) start , patient undergo clinical assessment interview local OCD-team , watch another video describe trial detail . They also assess SCID-I ( Structured Clinical Interview ) DSM 5 well Y-BOCS ( Yale-Brown Obsessive Compulsive Scale ) interview independent specially trained psychologist . The cET deliver `` individual group format '' implies patient : therapist-ratio 1:1 , treatment deliver group minimum 3 maximum 6 patient . All group lead specially train cET therapist , local therapist experience OCD-therapists familiar cET format . Day 1 treatment ( 3 h ) consist psychoeducation planning exposure task . Day 2 day 3 ( 8 h + contact even ) consist individually tailor therapist assist exposure number relevant trigger diversity setting . All exposure base LEaning Technique ( LET ) , patient train recognize urge ritualize start , actively approach trigger `` leaning anxiety '' . The exposure also design optimize learned inhibition . In addition individual exposure training , group meet three time throughout day . Day 2 Day 3 patient take study medication exposure start . The study medication D-Cycloserine ( DCS ) 250 mg , DCS 100 mg placebo . In afternoon Day 3 , patient ' relatives/ friend invite 2 h lecture/ psychoeducation OCD current treatment . Day 4 focus `` lesson learnt '' well plan / specify exposure task come three week . Before cET patient record data electronically via CheckWare ( electronic case report form database ) . The patient continue registration obsession compulsion 3 week post cET . One week cET post-assessment Y-BOCS perform independent assessor . After 3 month , patient invite individual visit clinic . 1 year 5 year post treatment , assessment team perform follow-up telephone interview . Measures anxiety , depression , global functioning , severity disorder , self-reported OCD-symptoms , sleep , quality life , change work social status well change medication use health care include employed secondary outcome . A total 14 expert therapist train deliver cET OCD-patients Norway . Patients , therapist assessor blind randomization . Interventions record rat compliance competence . All SCID-I Y-BOCS assessment record standard procedure rescoring follow . All assessor independent specially train . A Scientific Advisory Board establish , also include representative Norwegian OCD-association . The formal project partner Haukeland University Hospital ; Oslo University Hospital ; St Olavs Hospital ; Soerlandet Hospital Moere Romsdal Hospital .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>All 15 OCDteams Norway refer patient study , thus provide nationwide coverage relapse nonresponsive OCD patient . Through Norwegian National OCDimplementation project OCDpatients Norway ensure access evidence base treatment . Standardized procedure collection storage data ( quality database ) also establish . These data serve reference data standard treatment response , well provide detailed information regard first treatmentcourse relapse OCDpatients . The inclusion procedure implies relevant patient Norway give time period offer participation . If population turn few 160 patient study period , inclusion period might extend six month . If less 160 patient include point , analyse performed number patient include end study period . Outpatients ≥ 18 year Fulfilling diagnostic criterion OCD accord DSM5 Previously receive ERPtreatment deliver trained therapist either respond relapse , respond treatment . Response define ≥35 % reduction posttreatment YBOCS score ≤15 , follow relapse define &gt; 35 % increase YBOCS score posttreatment , YBOCS score 16 , Clinical Global ImpressionImprovement Scale ( CGII ) score 6 ( `` much bad '' ) high . Nonresponders define reduction YBOCS score pre postof le 35 % , YBOCS score ≥16 treatment . In order classify nonresponder oppose `` dropout '' patient previously receive minimum 6 session . There must minimum 4 week since treatment end . Fluent Norwegian Signed informed consent Exclusion Criteria related ERP : OCD symptom primarily associate hoard Ongoing substance abuse/dependence Bipolar disorder psychosis Ongoing suicidal ideation Mental Retardation , base previous medical history If use antidepressant : Not stable dosage 12 week intervention Unwilling remain stable dosage four intervention day Unwilling refrain anxiolytic ( e.g . benzodiazepine ) alcohol two day exposure . Living &gt; 1 hour drive car/ train treatment location . Exclusion Criteria related DCS : Pregnancy breast feeding ( participant inform use contraception two day DCS/placebo administer . Females ask pregnant , case doubt pregnancy test provide ) Renal impairment Hypersensitivity DCycloserine Porphyria Epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>OCD</keyword>
</DOC>